Cargando…

Octreotide for the Management of Gastrointestinal Bleeding in a Patient with a HeartWare Left Ventricular Assist Device

HeartWare is a third generation left ventricular assist device (LVAD), widely used for the management of advanced heart failure patients. These devices are frequently associated with a significant risk of gastrointestinal (GI) bleeding. The data for the management of patients with LVAD presenting wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dang, Geetanjali, Grayburn, Ryan, Lamb, Geoffrey, Umpierrez De Reguero, Adrian, Gaglianello, Nunzio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281453/ https://www.ncbi.nlm.nih.gov/pubmed/25587457 http://dx.doi.org/10.1155/2014/826453

Ejemplares similares

Comparison of left ventricular geometry after HeartMate II and HeartWare left ventricular assist device implantation
por: Hosseini, Morteza Tavakkoli, et al.
Publicado: (2013)

Early thrombus formation in patient with HeartWare left ventricular assist device presenting with acute heart failure
por: Ucar, Mustafa, et al.
Publicado: (2016)

Identifying patients at risk: multi‐centre comparison of HeartMate 3 and HeartWare left ventricular assist devices
por: Numan, Lieke, et al.
Publicado: (2023)

Effects of HeartWare ventricular assist device on the von Willebrand factor: results of an academic Belgian center
por: Esmaeilzadeh, Fatemeh, et al.
Publicado: (2016)

Treatment of device thrombus in the HeartWare HVAD: surgical exchange through thoracotomy
por: Ghandour, Amale, et al.
Publicado: (2021)

Evolution of thrombolytic therapy in patients with HeartWare ventricular assist device thrombosis: a single-institutional experience
por: Fox, Henrik, et al.
Publicado: (2022)

Propensity score‐based analysis of long‐term outcome of patients on HeartWare and HeartMate 3 left ventricular assist device support
por: Numan, Lieke, et al.
Publicado: (2021)

Emergency HeartWare Ventricular Assist Device (HVAD) exchange due to pump thrombosis using minimally invasive technique
por: Antończyk, Remigiusz, et al.
Publicado: (2017)

Identification of characteristics, risk factors, and predictors of recurrent LVAD thrombosis: conditions in HeartWare devices
por: Gyoten, Takayuki, et al.
Publicado: (2020)

HeartWare Thrombosis After mRNA COVID-19 Vaccination
por: Schettle, Sarah, et al.
Publicado: (2022)

Gastrointestinal Bleeding Rates in Left Ventricular Assist Device Population Reduced with Octreotide Utilization
por: Wilson, Tyler J., et al.
Publicado: (2020)

The History of Durable Left Ventricular Assist Devices and Comparison of Outcomes: HeartWare, HeartMate II, HeartMate 3, and the Future of Mechanical Circulatory Support
por: Berardi, Cecilia, et al.
Publicado: (2022)

Interpreting Neurologic Outcomes in a Changing Trial Design Landscape: An Analysis of HeartWare Left Ventricular Assist Device Using a Hybrid Intention to Treat Population
por: Mahr, Claudius, et al.
Publicado: (2019)

Design Concepts and Preclinical Results of a Miniaturized HeartWare Platform: The MVAD System
por: Cheung, Anson, et al.
Publicado: (2015)

Is flow really continuous in last generation continuous flow Ventricular Assist Devices? A comparison between HeartMate II and HeartWare HVAD
por: Melisurgo, G, et al.
Publicado: (2012)

Successful repeated thrombolysis in a patient with HeartWare thrombosis – the importance of Doppler flow pattern
por: Paluszkiewicz, Lech, et al.
Publicado: (2014)

Comparing short‐term outcome after implantation of the HeartWare® HVAD® and the Abbott® HeartMate 3®
por: Schramm, Rene, et al.
Publicado: (2020)

Successful bridge to recovery using two-stage HeartWare LVAD explantation approach after embolic stroke
por: Sabashnikov, Anton, et al.
Publicado: (2013)

First successful percutaneous treatment of a totally occluded HeartWare outflow graft: Case report and literature review
por: Kemaloğlu, Cemal, et al.
Publicado: (2018)

Mitral commissurotomy through the left ventricle apical orifice with Heart Ware left ventricular assist device implantation
por: Mohite, Prashant Nanasaheb, et al.
Publicado: (2013)

Continuous flow left ventricular assist devices and gastrointestinal bleeding
por: Turner, Katja R
Publicado: (2012)

Flow dynamics during the HeartWare HVAD to HeartMate 3 exchange: A computational study assessing differential graft lengths and surgical techniques
por: Grinstein, Jonathan, et al.
Publicado: (2022)

Gastrointestinal bleeding on continuous‐flow left ventricular assist device therapy
por: Hammer, Yoav, et al.
Publicado: (2023)

Gastrointestinal angiodysplasia is associated with significant gastrointestinal bleeding in patients with continuous left ventricular assist devices
por: Cochrane, Justin, et al.
Publicado: (2016)

Treatment of gastrointestinal bleeding in left ventricular assist devices: A comprehensive review
por: Vedachalam, Srikanth, et al.
Publicado: (2020)

A Multicenter Study of Left Ventricular Assist Device-Related Gastrointestinal Bleeding
por: Dailey, Joseph, et al.
Publicado: (2022)

Characterization and timing of gastrointestinal bleeding in continuous flow left ventricular assist device recipients
por: Kapuria, Devika, et al.
Publicado: (2020)

Clinical Approach to Manage Gastrointestinal Bleeding with a Left Ventricular Assist Device (LVAD)
por: Ahsan, Irfan, et al.
Publicado: (2019)

Novell IntranetWare/NetWare 5
por: Zacker, Craig
Publicado: (1999)

Clinical Predictors for Repeat Hospitalizations in Left Ventricular Assist Device (LVAD) Patients With Gastrointestinal Bleeding
por: Welden, Charles V., et al.
Publicado: (2018)

Outcomes of gastrointestinal bleeding in patients with left ventricular assist devices: a tertiary care experience
por: Taylor, Caren, et al.
Publicado: (2020)

Role of octreotide in small bowel bleeding
por: Khedr, Anwar, et al.
Publicado: (2022)

Colonel Waring
Publicado: (1899)

Pro/con debate: Octreotide has an important role in the treatment of gastrointestinal bleeding of unknown origin?
por: Arabi, Yaseen, et al.
Publicado: (2006)

Octreotide as an adjunct in the management of arterial gastrointestinal bleeding: Should it be considered in refractory cases of obscure origin?
por: Martins, Noel B., et al.
Publicado: (2017)

The Clinical Challenge of Refractory Octreotide-Induced Thrombocytopenia in Active Gastrointestinal Bleeding: A Case Report
por: Abu-Abaa, Mohammad, et al.
Publicado: (2023)

Safety and efficacy of single-balloon enteroscopy in management of gastrointestinal bleeding in patients with a left ventricular assist device
por: Koul, Abhinav, et al.
Publicado: (2017)

Initial endoscopic intervention is not associated with reduced risk of recurrent gastrointestinal bleeding in left ventricular assist device patients
por: Stern, Benjamin, et al.
Publicado: (2021)

Endoscopic Evaluation and Management of Gastrointestinal Bleeding in Patients with Ventricular Assist Devices
por: Meyer, Marty M., et al.
Publicado: (2012)

Does endoscopic intervention prevent subsequent gastrointestinal bleeding in patients with left ventricular assist devices? A retrospective study
por: Palchaudhuri, Sonali, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bo7c3sopipkdphvf8tbhe6mpo1